Resource Library

In life sciences, regulatory compliance is the foundation that protects patients, ensures product safety, and maintains the integrity of every organization in the field.

Whether developing...

Quality and risk management are inseparable in healthcare. One protects patients and drives improvement. The other prevents failures and safeguards the organization from operational,...

Compliance failures are rarely the result of a single mistake. They’re usually the product of small, preventable issues that snowball over time: a data field left incomplete during clinical...

In the pharmaceutical industry, managing quality risks is absolutely essential for ensuring patient safety, maintaining regulatory compliance, and optimizing operational efficiency. The ...

Bringing a new therapy to market in the European Union requires years of work across research, development, and compliance.

For medical device manufacturers, the Premarket Approval (PMA) process is the most rigorous path to market in the United States. Reserved for Class III devices that sustain life, prevent...

Last Updated: October 2026

What does a Biologics License Application (BLA) require, and how does FDA review it?

A BLA is the FDA submission required to market a biologic in the U.S. It must...

Generic drugs play a critical role in improving patient access and reducing healthcare costs. But bringing a generic to market is not a simple process. Companies must demonstrate that their...

The goal of an NDA application is to present a clear, defensible story across CMC, nonclinical, clinical, and labeling so reviewers can evaluate benefit and risk without searching for...

If you’re developing a new medical device and there’s no clear predicate on the market, you may be wondering whether the FDA’s De Novo pathway is the right route forward. The process can...

Last Updated: October 2026

What is a Clinical Trial Application (CTA), and how is it different from an IND?